ULTOMIRIS 300 mg/3 ml CONCENTRADO PARA SOLUCION PARA PERFUSION
ULTOMIRIS 300 mg/3 ml CONCENTRADO PARA SOLUCION PARA PERFUSION
Commercialized
Register Number
1191371002
Prescription Type
Uso Hospitalario
Authorization Date
Jun 10, 2021
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Route: VÍA INTRAVENOSA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1191371002
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
RAVULIZUMABActive
Quantity: 300 mg
Name: RAVULIZUMAB
ATC CLASSIFICATION (3)
L04A
L04AJ
L04AJ02